We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours

By LabMedica International staff writers
Posted on 04 Feb 2021
Print article
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
Image: Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours (Photo courtesy of Hubrecht Institute)
A new COVID-19 test robot can process up to 20,000 samples for SARS-CoV-2 testing per 24 hours, making it much faster than all other systems used to date.

The robot, called STRIP-1, developed by scientists at the Hubrecht Institute (Utrecht, the Netherlands) and Genmab (Copenhagen, Denmark) can not only process more tests in less time than any other machine known to date, but can also track all samples precisely, because they have a barcode that is scanned multiple times throughout the process. This also enables an automatic online return of test results to the tested persons. Because STRIP-1 can work with very small volumes, it uses less of the materials that are currently very scarce across the world. The costs per test will also be much lower than current testing costs. Lastly, using STRIP-1 will relieve overloaded laboratory personnel.

After successfully going through the validation procedure, the robot will be used for large scale testing. The Dutch government plans to order five more of such robots in the future, if the validation procedure indeed delivers the expected results. Together, these robots will be able to process more than 100,000 samples per 24 hours. The robots are not only useful during the current COVID-19 pandemic, but due to their modular structure, they can also be used for future pandemics. This enables large scale testing immediately, without overloading the regular diagnostic laboratories.

“While we were working on this, we realized that the gold standard of tests, the PCR test, works extremely well and that the biggest challenge was the logistics of it all,” said Wouter de Laat, one of the initiators of the project. “We hoped that we could organize everything in a faster and more intelligent way by using robots, so that became our focus almost immediately.”

Related Links:
Hubrecht Institute
Genmab


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more